Aummune
Sector: Healthcare & Life Sciences
About Aummune
Aummune develops a first-of-its-kind individual drug-customization platform that utilizes a unique efficacy-driven selection process to match and produce a patient-specific tri-functional aptamer drug that safely and synergistically induces cancer cell death and activates both innate and adaptive immune responses
Products
AM003
A New class of individualized immunotherapy AM003 is a unique, individualized therapy that has been designed to directly induce tumor cell death as well as to stimulate an anti-tumor immune response. The first-in-human Phase 1 is evaluating the safety and tolerability of AM003 in an open-label, multicenter, dose-escalation study of patients with locally advanced/metastatic solid tumors.